Subrini J, Varsally W, Balsells I, Bensberg M, Sioutas G, Ojarikre O
Science. 2025; 387(6732):393-400.
PMID: 39847625
PMC: 7617377.
DOI: 10.1126/science.ads6495.
Yuan X, Xu K, Yan F, Liu Z, Spetz C, Zhou H
Viruses. 2024; 16(9).
PMID: 39339858
PMC: 11436044.
DOI: 10.3390/v16091382.
Uribe-Salazar J, Kaya G, Weyenberg K, Radke B, Hino K, Soto D
bioRxiv. 2024; .
PMID: 39314374
PMC: 11418993.
DOI: 10.1101/2024.09.11.612570.
McKean D, Zhang Q, Narayan P, Morton S, Strohmenger V, Tang V
J Clin Invest. 2024; 134(11.
PMID: 38828726
PMC: 11142749.
DOI: 10.1172/JCI167811.
Camps G, Maestro S, Torella L, Herrero D, Usai C, Bilbao-Arribas M
PLoS Pathog. 2024; 20(5):e1011749.
PMID: 38739648
PMC: 11115361.
DOI: 10.1371/journal.ppat.1011749.
Development of pathophysiologically relevant models of sickle cell disease and β-thalassemia for therapeutic studies.
Gupta P, Goswami S, Kumari G, Saravanakumar V, Bhargava N, Rai A
Nat Commun. 2024; 15(1):1794.
PMID: 38413594
PMC: 10899644.
DOI: 10.1038/s41467-024-46036-x.
Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1.
Torella L, Klermund J, Bilbao-Arribas M, Tamayo I, Andrieux G, Chmielewski K
EMBO Mol Med. 2024; 16(1):112-131.
PMID: 38182795
PMC: 10897483.
DOI: 10.1038/s44321-023-00008-8.
CRISPR-Cas9-mediated somatic correction of a one-base deletion in the Ugt1a gene ameliorates hyperbilirubinemia in Crigler-Najjar syndrome mice.
Bortolussi G, Iaconcig A, Canarutto G, Porro F, Ferrucci F, Galletta C
Mol Ther Methods Clin Dev. 2023; 31:101161.
PMID: 38094199
PMC: 10716028.
DOI: 10.1016/j.omtm.2023.101161.
ZNF524 directly interacts with telomeric DNA and supports telomere integrity.
Braun H, Xu Z, Chang F, Viceconte N, Rane G, Levin M
Nat Commun. 2023; 14(1):8252.
PMID: 38086788
PMC: 10716145.
DOI: 10.1038/s41467-023-43397-7.
DNA polymerases in precise and predictable CRISPR/Cas9-mediated chromosomal rearrangements.
Mehryar M, Shi X, Li J, Wu Q
BMC Biol. 2023; 21(1):288.
PMID: 38066536
PMC: 10709867.
DOI: 10.1186/s12915-023-01784-y.
Genotyping MUltiplexed-Sequencing of CRISPR-Localized Editing (GMUSCLE): An Experimental and Computational Approach for Analyzing CRISPR-Edited Cells.
Zhang P, Abel L, Casanova J, Yang R
CRISPR J. 2023; 6(5):462-472.
PMID: 37824834
PMC: 10611965.
DOI: 10.1089/crispr.2023.0021.
Mutation Knock-in Methods Using Single-Stranded DNA and Gene Editing Tools in Zebrafish.
Prykhozhij S, Berman J
Methods Mol Biol. 2023; 2707:279-303.
PMID: 37668920
DOI: 10.1007/978-1-0716-3401-1_19.
Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo.
Neldeborg S, Soerensen J, Moller C, Bill M, Gao Z, Bak R
Leukemia. 2023; 37(9):1792-1801.
PMID: 37464068
PMC: 10457201.
DOI: 10.1038/s41375-023-01950-9.
Lipid droplets are a metabolic vulnerability in melanoma.
Lumaquin-Yin D, Montal E, Johns E, Baggiolini A, Huang T, Ma Y
Nat Commun. 2023; 14(1):3192.
PMID: 37268606
PMC: 10238408.
DOI: 10.1038/s41467-023-38831-9.
CRISPR-Analytics (CRISPR-A): A platform for precise analytics and simulations for gene editing.
Sanvicente-Garcia M, Garcia-Valiente A, Jouide S, Jaraba-Wallace J, Bautista E, Escobosa M
PLoS Comput Biol. 2023; 19(5):e1011137.
PMID: 37253059
PMC: 10256225.
DOI: 10.1371/journal.pcbi.1011137.
Identification of the EH CRISPR-Cas9 system on a metagenome and its application to genome engineering.
Esquerra-Ruvira B, Baquedano I, Ruiz R, Fernandez A, Montoliu L, Mojica F
Microb Biotechnol. 2023; 16(7):1505-1523.
PMID: 37097160
PMC: 10281378.
DOI: 10.1111/1751-7915.14266.
Current Bioinformatics Tools to Optimize CRISPR/Cas9 Experiments to Reduce Off-Target Effects.
Naeem M, Alkhnbashi O
Int J Mol Sci. 2023; 24(7).
PMID: 37047235
PMC: 10094584.
DOI: 10.3390/ijms24076261.
Evolution of CRISPR-associated endonucleases as inferred from resurrected proteins.
Alonso-Lerma B, Jabalera Y, Samperio S, Morin M, Fernandez A, Hille L
Nat Microbiol. 2023; 8(1):77-90.
PMID: 36593295
PMC: 10324499.
DOI: 10.1038/s41564-022-01265-y.
A comprehensive Bioconductor ecosystem for the design of CRISPR guide RNAs across nucleases and technologies.
Hoberecht L, Perampalam P, Lun A, Fortin J
Nat Commun. 2022; 13(1):6568.
PMID: 36323688
PMC: 9630310.
DOI: 10.1038/s41467-022-34320-7.
Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma.
Suresh S, Rabbie R, Garg M, Lumaquin D, Huang T, Montal E
Cancer Discov. 2022; 13(1):194-215.
PMID: 36259947
PMC: 9827116.
DOI: 10.1158/2159-8290.CD-22-0427.